During the CAPiTA trial, data was collected which gave a relevant picture of the impact of a pneumococcal vaccination in both the incidence and the course and treatment of Community Acquired Pneumonia (CAP). However, many doctors pointed out during the study that the collection of data on CAP in the second line is just the tip of the iceberg: the large majority of all patients with pneumonia are viewed and treated in a primary care setting.